Artikel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
Editorial
-
Tade Matthias Spranger
Veröffentlicht/Copyright:
28. November 2005
Abstract
In their fundamental overview on intellectual property and biotechnology, Victoria Jimenez and Dennis Fernandez not only deal with the top-10 most common intellectual property rights mistakes during venture capital due diligence, but also present a basic analysis of IP strategy in biotech. The article also discusses IP problems related to genomics, proteomics, pharmacogenomics, bioinformatics, biochips, and, last but not least, emerging technologies such as nanotechnology or biogenerics, and therefore provides an ideal tool for all those who are interested in the role of intellectual property in the field of biotech.
:
Published Online: 2005-11-28
Published in Print: 2005-11-25
Walter de Gruyter GmbH & Co. KG
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Artikel in diesem Heft
- Editorial
- Contents
- Author Index
- Subject Index
- Intellectual Property and Biotechnology
- International Regulation of Biotechnology: Problems and Prospects
- Group-Differentiated Rights and Informed Consent for Indigenous Group-Based Genetic Research
- Biotechnological Potential of Marine Sponges and their Associated Bacteria as Producers of New Pharmaceuticals (Part II)
Artikel in diesem Heft
- Editorial
- Contents
- Author Index
- Subject Index
- Intellectual Property and Biotechnology
- International Regulation of Biotechnology: Problems and Prospects
- Group-Differentiated Rights and Informed Consent for Indigenous Group-Based Genetic Research
- Biotechnological Potential of Marine Sponges and their Associated Bacteria as Producers of New Pharmaceuticals (Part II)
